Treatment of myelofibrosis in younger patients: to transplant or not?
Jabbour
Elias
E
Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.
Verstovsek
Srdan
S
D000328:Adult; D000367:Age Factors; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors* / Q000235:genetics*; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D055728:Primary Myelofibrosis / Q000188:drug therapy / Q000235:genetics*; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; C507924:JAK2 protein, human; D053614:Janus Kinase 2